These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation. Segal R; Grines LL; Pathak DS Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459 [TBL] [Abstract][Full Text] [Related]
7. National survey of selected hospital pharmacy practices. Stolar MH Am J Hosp Pharm; 1976 Mar; 33(3):225-30. PubMed ID: 1258882 [TBL] [Abstract][Full Text] [Related]
8. Experience with a two-tiered therapeutic interchange policy. Rich DS Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic substitution: has its time arrived? Doering PL; Russell WL; Klapp DL; McCormick WC Hosp Formul; 1984 Sep; 19(9):834-5 ,838-40. PubMed ID: 10267930 [TBL] [Abstract][Full Text] [Related]
10. Factors that influence prescribing decisions. Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259 [TBL] [Abstract][Full Text] [Related]
11. A physician survey on generic drugs and substitution of critical dose medications. Banahan BF; Kolassa EM Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664 [TBL] [Abstract][Full Text] [Related]
12. Influence of the British Columbia reference drug program on hospital formularies: a survey of hospital pharmacy managers. Gill NJ; Frighetto L; Marra C; Jewesson P Can J Clin Pharmacol; 2000; 7(2):109-14. PubMed ID: 10958707 [TBL] [Abstract][Full Text] [Related]
13. ASHP national survey of pharmaceutical services in federal hospitals--1993. Crawford SY; Santell JP Am J Hosp Pharm; 1994 Oct; 51(19):2377-93. PubMed ID: 7847403 [TBL] [Abstract][Full Text] [Related]
14. ASHP national survey of hospital-based pharmaceutical services--1992. Crawford SY; Myers CE Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Schachtner JM; Guharoy R; Medicis JJ; Newman N; Speizer R Am J Health Syst Pharm; 2002 Mar; 59(6):529-33. PubMed ID: 11908245 [TBL] [Abstract][Full Text] [Related]
16. Evaluating a restrictive formulary system by assessing nonformulary-drug requests. Green JA; Chawla AK; Fong PA Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350 [TBL] [Abstract][Full Text] [Related]
17. Cephalosporin-use restrictions in teaching hospitals. McCloskey WW; Johnson PN; Jeffrey LP Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437 [TBL] [Abstract][Full Text] [Related]
18. 'Generic substitution' in New Jersey, 1979-87. Culkin TT; Mendell S Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782 [TBL] [Abstract][Full Text] [Related]
19. Physicians' attitudes toward generic drug substitution by pharmacists. Brust M; Hawkins CF; Grayson D Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636 [TBL] [Abstract][Full Text] [Related]
20. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978. Sumner ED; Karig AW; Hunt HH Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]